BEAM
Price
$20.01
Change
+$0.13 (+0.65%)
Updated
Jul 3 closing price
Capitalization
2.01B
39 days until earnings call
FENC
Price
$8.80
Change
+$0.26 (+3.04%)
Updated
Jul 3 closing price
Capitalization
240.63M
34 days until earnings call
Interact to see
Advertisement

BEAM vs FENC

Header iconBEAM vs FENC Comparison
Open Charts BEAM vs FENCBanner chart's image
Beam Therapeutics
Price$20.01
Change+$0.13 (+0.65%)
Volume$1.36M
Capitalization2.01B
Fennec Pharmaceuticals
Price$8.80
Change+$0.26 (+3.04%)
Volume$80.32K
Capitalization240.63M
BEAM vs FENC Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. FENC commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and FENC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (BEAM: $20.01 vs. FENC: $8.80)
Brand notoriety: BEAM and FENC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 72% vs. FENC: 88%
Market capitalization -- BEAM: $2.01B vs. FENC: $240.63M
BEAM [@Biotechnology] is valued at $2.01B. FENC’s [@Biotechnology] market capitalization is $240.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileFENC’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • FENC’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than FENC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while FENC’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • FENC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, FENC is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +16.74% price change this week, while FENC (@Biotechnology) price change was +6.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

FENC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.01B) has a higher market cap than FENC($241M). FENC YTD gains are higher at: 39.241 vs. BEAM (-19.315). FENC has higher annual earnings (EBITDA): -10.34M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. FENC (22.7M). FENC has less debt than BEAM: FENC (19.4M) vs BEAM (158M). BEAM has higher revenues than FENC: BEAM (63.6M) vs FENC (30.9M).
BEAMFENCBEAM / FENC
Capitalization2.01B241M835%
EBITDA-399.03M-10.34M3,858%
Gain YTD-19.31539.241-49%
P/E RatioN/A64.14-
Revenue63.6M30.9M206%
Total Cash1.22B22.7M5,374%
Total Debt158M19.4M814%
FUNDAMENTALS RATINGS
FENC: Fundamental Ratings
FENC
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
88
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMFENC
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 8 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HBSI35.000.87
+2.55%
Highlands Bankshares, Inc.
PLLIF6.84N/A
N/A
Pirelli S.p.A.
BXXRF0.06N/A
N/A
Exgen Resources Inc.
CADNF6.74N/A
N/A
Cascades Inc.
FNCTF15.60N/A
N/A
Orange

FENC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FENC has been loosely correlated with DNLI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if FENC jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FENC
1D Price
Change %
FENC100%
+3.04%
DNLI - FENC
46%
Loosely correlated
-1.41%
BEAM - FENC
45%
Loosely correlated
+0.65%
CLDX - FENC
45%
Loosely correlated
-0.50%
IDYA - FENC
44%
Loosely correlated
+0.82%
ATXS - FENC
42%
Loosely correlated
+1.40%
More